Use access key #2 to skip to page content.
$41.46 -0.07 (-0.17%)
11/21/2008 4:00 PM

Gilead Sciences, Inc. (GILD)

CAPS Rating:
****

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

View All Commentary (GILD)

Recs

0

Avatar unluckyatlove (57.26) Submitted: 11/29/07 2:01 PM : Outperform Start Price: $45.50 GILD Score: 39.50

This bio tech company is a leader in this industry with few liabilities. They own Tamaflu for bird flu and have abn outstanding licscensing agreement with Roche. Any big outbreak or scare would give them a big bonus 22% of sales

Report this Post Replies: 1 | Reply | Permalink

Avatar RUFFOPTIONS (< 20) Submitted: 3/14/08 9:12 AM

Recs: 0 | Rec This

.....and technically, it has held up extremely well in this choppy market---a very good sign indeed. Those that hang in the best during tough times, go up the best when all the dust settles

Report this Post Reply

Featured Broker Partners

Sponsored Links